Baker Bros. Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-11,660,432
| Closed | -$1.14B | – | 135 |
|
|
2015
Q1 | $1.14B | Buy |
11,660,432
+1,000,000
| +9% | +$97.5M | 9.46% | 3 |
|
|
2014
Q4 | $989M | Hold |
10,660,432
| – | – | 10.1% | 3 |
|
|
2014
Q3 | $733M | Hold |
10,660,432
| – | – | 9.23% | 4 |
|
|
2014
Q2 | $1.12B | Buy |
10,660,432
+12,250
| +0.1% | +$1.28M | 13.68% | 1 |
|
|
2014
Q1 | $883M | Buy |
10,648,182
+375,000
| +4% | +$31.1M | 11.23% | 2 |
|
|
2013
Q4 | $665M | Hold |
10,273,182
| – | – | 9.37% | 4 |
|
|
2013
Q3 | $651M | Buy |
10,273,182
+1,050,000
| +11% | +$66.6M | 9.26% | 4 |
|
|
2013
Q2 | $387M | Buy |
+9,223,182
| New | +$387M | 7.66% | 5 |
|